Deficient RPE mitochondrial energetics leads to subretinal fibrosis in age-related neovascular macular degeneration

Deficient RPE mitochondrial energetics leads to subretinal fibrosis in age-related neovascular macular degeneration

Subretinal fibrosis permanently impairs the vision of patients with neovascular age-related macular degeneration. Despite emerging evidence revealing the association between disturbed metabolism in retinal pigment epithelium (RPE) and subretinal fibrosis, the underlying mechanism remains unclear. In...

Full description

Bibliographic Details
Main Authors:	Ma, X, Wu, W, Hara, M, Zhou, J, Panzarin, C, Schafer, CM, Griffin, CT, Cai, J, Ma, J, Takahashi, Y
Format:	Journal article
Language:	English
Published:	Nature Research 2024

Similar Items

Radiotherapy for neovascular age-related macular degeneration.
by: Evans, JR, et al.
Published: (2010)

Optical coherence tomography in neovascular age-related macular degeneration
by: Chong, V
Published: (2012)

Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data
by: Spaide, Richard F., et al.
Published: (2021)

Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
by: Chakravarthy, U, et al.
Published: (2012)

Colour photographs for screening in neovascular age-related macular degeneration: are they necessary?
by: Hibbs, S, et al.
Published: (2011)

Evolving European guidance on the medical management of neovascular age related macular degeneration.
by: Chakravarthy, U, et al.
Published: (2006)

Modulation of Sub-RPE deposits in vitro: a potential model for age-related macular degeneration.
by: Amin, S, et al.
Published: (2004)

Quality of fixation in eyes with neovascular age-related macular degeneration treated with ranibizumab.
by: Sivaprasad, S, et al.
Published: (2011)

Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization.
by: Morohoshi, K, et al.
Published: (2012)

Treat-And-extend bevacizumab for neovascular age-related macular degeneration: The importance of baseline characteristics
by: Rush, R, et al.
Published: (2014)

Quantitative Optical Coherence Tomography Angiography of Choroidal Neovascularization in Age-Related Macular Degeneration
by: Jia, Yali, et al.
Published: (2015)

Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration
by: von der Emde, L, et al.
Published: (2019)

Second eye of patients with unilateral neovascular age-related macular degeneration: Caucasians vs Chinese.
by: Sivaprasad, S, et al.
Published: (2006)

Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).
by: Schmidt-Erfurth, U, et al.
Published: (2014)

Deliberations of an International Panel of Experts on OCT Angiography Nomenclature of Neovascular Age-Related Macular Degeneration
by: Mendonça, Luísa SM, et al.
Published: (2022)

Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration.
by: Maclaren, R, et al.
Published: (2007)

Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration.
by: Maclaren, R, et al.
Published: (2005)

Type 1 choroidal neovascularization is associated with reduced localized progression of atrophy in age-related macular degeneration
by: Pfau, M, et al.
Published: (2019)

Long-Term intraocular pressure changes in patients with neovascular age-related macular degeneration treated with Ranibizumab
by: Menke, Marcel N., et al.
Published: (2013)

rs10737680 polymorphism in complement factor H and neovascular age-related macular degeneration in Yogyakarta, Indonesia
by: Sigalingging, Talenta, et al.
Published: (2022)

Association of the HtrA1 rs11200638 Polymorphism with Neovascular Age-Related Macular Degeneration in Indonesia
by: Supanji, Supanji, et al.
Published: (2021)

Comparing fixation location and stability in patients with neovascular age-related macular degeneration treated with or without Ranibizumab.
by: Pearce, E, et al.
Published: (2011)

Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies.
by: Schmidt-Erfurth, U, et al.
Published: (2014)

Intravitreal aflibercept injection for neovascular age-related macular degeneration: Ninety-six-week results of the VIEW studies
by: Schmidt-Erfurth, U, et al.
Published: (2014)

Early detection of neovascular age-related macular degeneration: an economic evaluation based on data from the EDNA study
by: Hernandez, R, et al.
Published: (2021)

Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration.
by: Saleh, Rafidah, et al.
Published: (2017)

Pharmacogenetic Associations with Vascular Endothelial Growth Factor Inhibition in Participants with Neovascular Age-Related Macular Degeneration in the IVAN Study
by: Lotery, A, et al.
Published: (2013)

Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the ivan study
by: Lotery, A, et al.
Published: (2013)

Favorable visual outcome associated with subretinal indocyanine green in macular hole surgery.
by: Fletcher, E, et al.
Published: (2004)

Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
by: Ross, A, et al.
Published: (2013)

Development of a murine model of age-related macular degeneration by overexpression of complement component 3 in the RPE of MCP-1(-/-) and wild-type mice
by: Barker, SE, et al.
Published: (2008)

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration.
by: Hageman, G, et al.
Published: (2001)

Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema
by: Borchert, GA, et al.
Published: (2024)

SPATIAL DISTRIBUTION OF CHORIOCAPILLARIS IMPAIRMENT IN EYES WITH CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION: A Quantitative OCT Angiography Study
by: Moult, Eric M, et al.
Published: (2021)

Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.
by: Chakravarthy, U, et al.
Published: (2012)

Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: One-year findings from the IVAN randomized trial
by: Chakravarthy, U, et al.
Published: (2012)

Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial
by: Jackson, TL, et al.
Published: (2024)

Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study
by: Banister, K, et al.
Published: (2022)

Long-term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration.
by: Chen, F, et al.
Published: (2009)

The long-term effects of anti-vascular endothelial growth factor therapy on the optical coherence tomography angiographic appearance of neovascularization in age-related macular degeneration
by: Levine, Emily S., et al.
Published: (2020)